http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106317194-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-02 |
filingDate | 2015-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106317194-B |
titleOfInvention | Ring histidyl--KARPAK, synthesis, thrombus related activity and application |
abstract | The invention discloses following formula ring histidyl--KARPAK (6s) -4,5,6,7- tetrahydro -3H- imidazoles [4,5-c] and pyridine -6- formyl-Lys-Ala-Arg-Pro-Ala-Lys, its preparation method is disclosed, the effect that it treats rats with stroke is disclosed, thus the invention discloses it, and the application treated in hemorrhagic apoplexy drug is lacked in preparation. |
priorityDate | 2015-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.